Abstract
The aim of the study was to evaluate the subset distribution and the IL-2 R p55–p75 subunit expression on unstimulated and phytohemagglutinin (PHA)-stimulated (at 3-d) peripheral blood mononuclear cells (PBMC), of patients with solid cancers of different sites. Indeed the expression of the two subunits of IL-2R is an essential prerequisite for The action of the IL-2 on CD8+, CD16+ lymphocytes as effectors in antitumor activity (LAK-cells). The subset distribution (CD3, CD4, CD8, CD16, DR) was assessed by cytofluorometry with specific monoclonal antibodies (MAbs); the p55 (CD25) and p75 subunit expression was evaluated by specific MAb (OKT26a and anti-p75). Ninety patients with advanced cancer (mainly non-small cell lung cancer [NSCLC], head and neck cancer, and gynecological cancer; mean age 55 yr; range 27–80) were studied. Thirty-five age- and sex-matched healthy subjects were studied as controls. Our data show that there is no significant difference in the subset distribution between cancer patients and controls. Furthermore, no difference has been found in the expression of p55 subunits on unstimulated PBMC between cancer patients and controls. No difference has been found in the expression of both p55 and p75 subunits on PHA-stimulated PBMC between cancer patients and controls. Our results can support the rationale for further clinical trials with IL-2 in solid malignancies.
Access this article
We’re sorry, something doesn't seem to be working properly.
Please try refreshing the page. If that doesn't work, please contact support so we can address the problem.
Similar content being viewed by others
References
Herberman, R. B. (1983)Progress in Immunology. (Tata, T., ed.), Academic, Tokyo, pp. 1157–1167.
Gorelik, E. and Herberman, R. B. (1989)Fundamental Aspects of the Cancer: Cancer growth and progression. (Kaiser, V. I., ed.), Kluwer, Dordrecht, pp. 134–143.
Ricevuti, G., Mazzone, A., Pasotti, D., and Notario, A. (1992)Int. J. Immunopathol. Pharmacol. 5, 67–76.
Smith, K. A. (1988)Science 240, 1169–1176.
Diamantstein, T. (1990)Biology and Clinical Applications of IL 2. (Rees, R. C., ed.), Oxford University Press, Oxford, pp. 15–22.
Dower, S. K., Smith, C. A., and Park, L. S. (1990)J. Clin. Immunol. 10, 289–299.
Rosenberg, S. A. (1988)Immunol. Today 9, 58–62.
Mantovani, G., Coiana, A., Massidda, A., Proto, E., Floris, C., Pusceddu, G., et al. (1988)Cancer Detect. Prev. 12, 149–159.
Maccio, A., Mantovani, G., Serri, F. G., Mauri, A., Andria, G., Arangino, V., et al. (1990)J. Immunol. Res. 2, 90–94.
Mantovani, G., Coiana, A., Cossu, F., Floris, C., Proto, E., Maccio, A., et al. (1986)Tumori 72, 375–382.
Mantovani, G., Coiana, A., Massidda, A., Proto, E., Floris, C., Maccio, A., et al. (1987)Diagn. Clin. Immunol. 5, 104–111.
Rosenberg, S. A. (1988)Immunol. Today 9, 58–62.
Rosenberg, S. A., Lotze, M. T., Muul, L. M., Chang, A. E., Avis, F. P., Leitman, S., et al. (1987)N. Engl. J. Med. 316, 889–897.
Voss, S. D., Hank, J. A., Nobis, C. A., Fisch, P., Sosman, J. A., and Sondel, P. M. (1989)Cancer Immunol. Immunother. 29, 261–269.
West, W. H., Tauer, K. W., Yannelli, J. R., Marshall, G. D., Orr, D. W., Thurman, G. B., et al. (1987)N. Engl. J. Med. 316, 898–905.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Mantovani, G., Macciò, A., Lai, P. et al. Study of peripheral blood lymphocyte subset distribution and IL-2 receptor (IL-2 R) p55–p75 subunit expression in patients with cancer of different sites. Cell Biophysics 24, 301–305 (1994). https://doi.org/10.1007/BF02789241
Issue Date:
DOI: https://doi.org/10.1007/BF02789241